Clinical trial
Evaluation of the Clinical Efficacy of Antrrix Probiotics in Improving Recurrent Respiratory Infections in Infants and Young Children
NCT07297966 is registered in ClinicalTrials.gov with Min-Tze LIONG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Clinical Efficacy of Antrrix Probiotics in Improving Recurrent Respiratory Infections in Infants and Young Children
- Lead sponsor
- Min-Tze LIONG
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- May 14, 2025
- Completion date
- June 30, 2026
- Enrollment
- 120 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
recurrent respiratory tract infections